• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Mccabe Robert A Jr bought $28,768 worth of Shares Of Common Stock (437 units at $65.83), increasing direct ownership by 2% to 21,585 units (SEC Form 4)

    5/31/24 4:20:07 PM ET
    $NHI
    Real Estate Investment Trusts
    Real Estate
    Get the next $NHI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    MCCABE ROBERT A JR

    (Last) (First) (Middle)
    150 3RD AVENUE NORTH
    SUITE 800

    (Street)
    NASHVILLE TN 37201

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    NATIONAL HEALTH INVESTORS INC [ NHI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/31/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Shares Of Common Stock 05/31/2024 P 437 A $65.8312 21,585 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Stock Options (Right to Buy) 2-21-2020 $90.79 02/21/2020 02/21/2025 Common Stock 25,000 25,000 D
    Stock Options (Right to Buy) 2-25-2021 $69.2 02/25/2021 02/25/2026 Common Stock 25,000 25,000 D
    Stock Option (Right to buy) 2022 $53.41 02/25/2022 02/25/2027 Common Stock 25,000 25,000 D
    Stock Option (Right to Buy) 2023 $54.73 02/24/2023 02/24/2028 Common Stock 10,000 10,000 D
    Stock Option (Right to Buy) 2024 $57.76 02/23/2024 02/23/2029 Common Stock 10,000 10,000 D
    Explanation of Responses:
    /s/ Kimberly V. Ouimet, by limited power of attorney 05/31/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $NHI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NHI

    DatePrice TargetRatingAnalyst
    10/1/2024$81.00 → $86.00Overweight → Equal Weight
    Wells Fargo
    9/24/2024$92.00Buy
    BofA Securities
    3/12/2024$67.00Market Perform → Outperform
    BMO Capital Markets
    2/26/2024$55.00 → $63.00Equal Weight → Overweight
    Wells Fargo
    2/26/2024$57.00 → $64.00Neutral → Outperform
    Wedbush
    1/30/2024$69.00Buy
    Deutsche Bank
    10/3/2023$54.00Neutral
    Wedbush
    9/28/2023$54.00Hold
    Berenberg
    More analyst ratings

    $NHI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • National Health downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded National Health from Overweight to Equal Weight and set a new price target of $86.00 from $81.00 previously

      10/1/24 7:48:30 AM ET
      $NHI
      Real Estate Investment Trusts
      Real Estate
    • BofA Securities initiated coverage on National Health with a new price target

      BofA Securities initiated coverage of National Health with a rating of Buy and set a new price target of $92.00

      9/24/24 8:20:41 AM ET
      $NHI
      Real Estate Investment Trusts
      Real Estate
    • National Health upgraded by BMO Capital Markets with a new price target

      BMO Capital Markets upgraded National Health from Market Perform to Outperform and set a new price target of $67.00

      3/12/24 7:30:12 AM ET
      $NHI
      Real Estate Investment Trusts
      Real Estate

    $NHI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Mccabe Robert A Jr bought $28,768 worth of Shares Of Common Stock (437 units at $65.83), increasing direct ownership by 2% to 21,585 units (SEC Form 4)

      4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)

      5/31/24 4:20:07 PM ET
      $NHI
      Real Estate Investment Trusts
      Real Estate
    • Swafford Charlotte A bought $586,882 worth of shares (10,000 units at $58.69) (SEC Form 4)

      4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)

      2/28/24 6:20:46 PM ET
      $NHI
      Real Estate Investment Trusts
      Real Estate

    $NHI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Chapin Robert

      4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)

      5/12/25 4:34:20 PM ET
      $NHI
      Real Estate Investment Trusts
      Real Estate
    • CFO/EVP Finance Spaid John L covered exercise/tax liability with 259 shares, decreasing direct ownership by 0.58% to 44,424 units (SEC Form 4)

      4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)

      5/7/25 4:17:51 PM ET
      $NHI
      Real Estate Investment Trusts
      Real Estate
    • CEO and President Mendelsohn D. Eric covered exercise/tax liability with 394 shares, decreasing direct ownership by 0.41% to 96,133 units (SEC Form 4)

      4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)

      5/7/25 4:06:59 PM ET
      $NHI
      Real Estate Investment Trusts
      Real Estate

    $NHI
    SEC Filings

    See more
    • National Health Investors Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)

      6/2/25 4:12:29 PM ET
      $NHI
      Real Estate Investment Trusts
      Real Estate
    • National Health Investors Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)

      5/28/25 4:06:10 PM ET
      $NHI
      Real Estate Investment Trusts
      Real Estate
    • SEC Form DEFA14A filed by National Health Investors Inc.

      DEFA14A - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)

      5/13/25 4:34:12 PM ET
      $NHI
      Real Estate Investment Trusts
      Real Estate